Nature-Inspired Anticancer Agents: The Synergy of Phytochemicals and Synthetic Analogs (2019-2024)

Area of Science:

• Oncology
• Pharmacology
• Natural Product Chemistry

Background:

• Cancer is a leading global health challenge with limitations in current treatments like specificity, resistance, and toxicity.
• Natural products, especially phytochemicals, offer a promising avenue for novel anticancer therapies.
• These compounds target critical molecular pathways involved in cancer progression.

Purpose of the Study:

• To review recent advancements (2019-2024) in phytochemical research for cancer treatment.
• To explore natural product-inspired synthetic derivatives with enhanced therapeutic potential.
• To provide mechanistic insights into the anticancer activities of phytochemicals and their analogs.

Main Methods:

• Comprehensive literature survey of databases including PubMed, Scopus, Web of Science, and Google Scholar.
• Keywords used encompassed "phytochemicals," "natural products," "cancer," "anticancer agents," "kinase inhibitors," "EGFR," "HER2," "aromatase," and "synthetic analogs."
• Article selection based on relevance, recency, and impact in the field.

Main Results:

• Phytochemicals like vinca alkaloids, curcuminoids, flavonoids, terpenoids, and polyphenols exhibit potent anticancer properties.
• These compounds target key molecular pathways such as protein kinases, aromatase, EGFR, TNF-α, HER-2, and caspases.
• Synthetic derivatives of natural products show enhanced therapeutic potential.

Conclusions:

• Phytochemicals and their synthetic derivatives are critical in addressing current limitations in cancer therapy.
• Understanding their mechanisms of action is vital for developing novel and effective cancer treatments.
• This field holds significant promise for shaping future cancer therapeutic strategies.